Skip to content

Evaluation of an Oat Fiber Supplement on Health

Evaluation of an Oat Fiber Supplement on Health

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07714135
Enrollment
40
Registered
2026-07-20
Start date
2026-10-01
Completion date
2027-07-01
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supplementation Efficacy in Health Adults on Plasticizer Removal

Keywords

Oat FIber, supplementation, metabolic health, BPA

Brief summary

The purpose of the study is to determine whether short-term use of an oat fiber supplement reduces exposure to your urine levels of dietary chemicals like bisphenol A (BPA). This study will also examine whether supplementation with NeutraOat oat fiber influences blood glucose levels using continuous glucose monitoring.

Detailed description

The purpose of this study is to evaluate whether short-term supplementation of oat fiber reduces exposure to plasticizers following a controlled dietary exposure and whether any resulting changes influence glycemic responses.

Interventions

DIETARY_SUPPLEMENTOat Fiber

4 grams of supplementation by capsule per day for two days

DIETARY_SUPPLEMENTPlacebo

4 grams of supplementation (placebo) by capsule per day for two days

Sponsors

California Polytechnic State University-San Luis Obispo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants will be healthy * Weight-stable for the previous 6 months * Free of any metabolic or chronic disease * Non-smoking (to include vaping and other nicotine or THC containing products) * Participate in less than 250 minutes of moderate to vigorous physical activity per week

Exclusion criteria

* Any chronic or metabolic disease, including type 1 or type 2 diabetes * Gastrointestinal (GI) diseases/disorders * Neurologic or psychiatric conditions * Nicotine or THC consumption * Unsafe dieting practices * Special diets (e.g. vegan, low-carbohydrate, gluten-free, dairy-free, etc.)

Design outcomes

Primary

MeasureTime frameDescription
Urine Plasticizer ConcentrationUrine samples will be take over the course of three weeks.Plasticizer concentration in urine samples measured before and after oat fiber supplementation.

Secondary

MeasureTime frameDescription
Blood Glucose LevelsBlood glucose levels will be monitored over the course of 3 weeks.Blood glucose levels before and after supplementation with oat fiber.

Countries

United States

Contacts

CONTACTTodd Hagobian, PhD
thagobia@calpoly.edu805-756-7511

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026